Real-time enrollment status for this end-stage kidney disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT05828823 |
| Recruiting Status | Recruiting |
| Condition | End-Stage Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 350 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Wake Forest University Health Sciences |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 13, 2026: Clinical trial NCT05828823 is currently recruiting participants. This clinical trial study for end-stage kidney disease is actively seeking new participants at 10 locations across the United States. The study is sponsored by Wake Forest University Health Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05828823 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05828823 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.